PegBio Co., Ltd.

HK$3.42As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2565Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (125.57%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (94.32%)
Mkt cap HK$1.336B
ROIC (51.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.95
15.54%
(88.35%)
Hold 8|12|5|6|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.06
0.06
0.06
16.58%
18.32%
20.59%
8.91%
Revenue¥M
73.55
76.80
74.55
72.41
6.11%
7.76%
2.79%
(3.99%)
Peers (US$170.4M)
Cap (US$)
PE
173.9M
—
168.3M
—
171.1M
—
Capital
TTM
5Y
10Y
Leveragex
1.281
0.174
0.129
EBIT/Intx
5.921
0.179
0.162
Own earn%
(305.62)
217.49
206.82
Sh yield%
26.70
40.57
39.84
Owners
Insiders/Inst%
5.55
39.94
Short interest%
5.29
SBC / revenue%
4.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
2–7
$1 testx
0.0
Incr. ROIC%
8